AI Article Synopsis
- The NCCN Clinical Practice Guidelines for Breast Cancer provide comprehensive management strategies for the disease, particularly for metastatic cases.
- The treatment of metastatic breast cancer is continually evolving, taking into account tumor biology and various clinical factors, offering multiple treatment options if one fails.
- The latest NCCN Guidelines Insights report highlights recent updates on systemic therapy recommendations specifically for patients with stage IV (M1) breast cancer.
Article Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer address all aspects of management for breast cancer. The treatment landscape of metastatic breast cancer is evolving constantly. The therapeutic strategy takes into consideration tumor biology, biomarkers, and other clinical factors. Due to the growing number of treatment options, if one option fails, there is usually another line of therapy available, providing meaningful improvements in survival. This NCCN Guidelines Insights report focuses on recent updates specific to systemic therapy recommendations for patients with stage IV (M1) disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.6004/jnccn.2023.0031 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!